Markus Y. Mapara

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

Haydar Frangoul, David Altshuler, Maria Domenica Cappellini et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Life Sciences, Genetics, Hematology +17

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

Ralf C. Bargou, Florian Emmerich, Daniel Krappmann et al. · Journal of Clinical Investigation · 1997 · 765 citations · Full text

Medicine, Cell Biology, Oncology +15

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

Philippe Armand, Arnon Nagler, Edie Weller et al. · Journal of Clinical Oncology · 2013 · 439 citations · Full text

Medicine, Hematology, Oncology +17

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

Ralf C. Bargou, Karsten Jürchott, Christian Wagener et al. · Nature Medicine · 1997 · 425 citations

Medicine, Molecular Biology, Oncology +8

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Haydar Frangoul, Franco Locatelli, Akshay Sharma et al. · New England Journal of Medicine · 2024 · 380 citations

Life Sciences, Genetics, Hematology +17